PARIS Sanofi: No proof that vac­cine linked to Philip­pines deaths

The Myanmar Times - Weekend - - Asean Focus - AP

Drug­maker Sanofi in­sists there’s no ev­i­dence of a link be­tween the world’s first dengue vac­cine and chil­dren’s deaths in the Philip­pines.

Paris-based Sanofi said Wed­nes­day it lost 19 mil­lion eu­ros in the fourth quar­ter on the vac­cine as it bought back un­used medicines, but doesn’t ex­pect fur­ther re­lated losses this year.

CEO Olivier Brandi­court called con­cerns about the vac­cine “very wor­ri­some” but said no prob­lems were re­ported out­side the Philip­pines. He said “we have ab­so­lutely no ev­i­dence that the vac­cine has been linked to any deaths.”

Sanofi said in Novem­ber that the vac­cine could put peo­ple at risk of se­vere dis­ease if they hadn’t pre­vi­ously been in­fected.

Philip­pines au­thor­i­ties say the deaths of three chil­dren may have “causal as­so­ci­a­tion” to the vac­cine, and the gov­ern­ment wants a re­fund from Sanofi. –

Newspapers in English

Newspapers from Myanmar

© PressReader. All rights reserved.